Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Kierstead

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human bloodW Herr, E Ranieri, A Gambotto, et al.
Immunological Investigations|June 15, 2000
Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreadingE Ranieri, L S Kierstead, H Zarour, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cellsH M Zarour, J M Kirkwood, L S Kierstead, et al.
Journal of Virology|November 13, 1999
Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccinationE Ranieri, W Herr, A Gambotto, et al.
British Journal of Cancer|December 18, 2001
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cellsL S Kierstead, E Ranieri, W Olson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human bloodW Herr, E Ranieri, A Gambotto, et al.
Immunological Investigations|June 15, 2000
Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreadingE Ranieri, L S Kierstead, H Zarour, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cellsH M Zarour, J M Kirkwood, L S Kierstead, et al.
Journal of Virology|November 13, 1999
Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccinationE Ranieri, W Herr, A Gambotto, et al.
British Journal of Cancer|December 18, 2001
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cellsL S Kierstead, E Ranieri, W Olson, et al.
Pageof 1